Loading…
Student sign-up timeline:
  • Monday, November 18 @ 3:15 – 12th Grade
  • Tuesday, November 19 @ 3:15 – 11th Grade
  • Wednesday, November 20 @ 3:15 – 10th Grade
  • Thursday, November 21 @ 3:15 – 9th Grade
  • November 21-30 – Sign-ups/changes open to all. After December 1, schedules will be frozen.

to bookmark your favorites and sync them to your phone or calendar.

strong>Business and Finance [clear filter]
arrow_back View All Dates
Friday, January 10
 

8:55am PST

The Economics and Ethics of Shein
Friday January 10, 2025 8:55am - 10:10am PST
TBA
Shein seemingly came out of nowhere during COVID, becoming the #1 most downloaded shopping app in 61 countries (including the U.S.) and growing from less than $1B to over $20B in sales in the U.S. in only a few years.   

- How did Shein achieve such a meteoric rise? 
- How can Shein get you such fashionable looks for so cheap? How do they make money?
- Can they sustain this success even with regulatory and ethical pressure?

Through the lens of Shein, learn about how different types of fashion retailers design and source products and get them from overseas to your closet - and how they make money! We will also discuss regulatory and ethical issues in fashion, including labor and environmental practices. 

If you own anything from Shein bring it to class so we can use some real-life examples!
Facilitators
DS

Delaney Steele

Delaney Steele is an Executive Vice President at Ross Stores, which sells apparel, footwear and homegoods in about 2,000 stores. Delaney oversees various functions at Ross including Product Development and Sourcing, with sourcing offices in India and China.  She is also an adjust... Read More →
Friday January 10, 2025 8:55am - 10:10am PST
TBA
  1 Block

1:55pm PST

Innovation, Science, and FDA: How Do New Medicines Get To Patients?
Friday January 10, 2025 1:55pm - 3:10pm PST
WRC
It takes an average of $1.3 billion and more than 10 years to bring a new medicine to the point of applying for FDA approval. After pursuing this long and often tortuous path, the prospects are risky, and the FDA faces a binary choice: Grant marketing authorization, or reject the application?

What does the drug development process entail, and why is it so long, expensive, and complex? What is FDA's role in protecting American consumers and the public? How are the concepts of "benefit" and "risk" used to provide a framework for these decisions?

In this interactive session, you will learn the basics of the drug development process, including the role of the FDA in deciding whether to allow access to new drugs. Students will work in groups to evaluate whether a new drug should be "approved", and, if so, under what conditions.
Facilitators
avatar for Thomas Chalberg

Thomas Chalberg

Founder & Managing Director, Polymerase Capital
Thomas W. Chalberg, PhD is an investor, scientist, and biotechnology entrepreneur. He is currently Managing Director of Polymerase Capital, where his investments have included Genascence Corporation and Exhaura. Prior to this, Dr. Chalberg was the Founder & CEO of SightGlass Vision... Read More →
Friday January 10, 2025 1:55pm - 3:10pm PST
WRC
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.
Filtered by Date -